HAM/TSP patients with low neuroinflammation activity, as indicated by the CSF/serum ratio of neopterin and CXCL10, had higher serum fractalkine/CX3CL1 levels compared to patients with active neuroinflammation. This evidence concerns the gene CXCL10 and tropical spastic paraparesis.